A potentially deadly drug manufactured by pharmaceutical giant AstraZeneca has been linked to the deaths of soldiers returning from war. Yet the FDA continues to approve it.
Ninety-two percent of FDA advisory meetings in the last decade included a member with financial ties to drug companies. A look at how that affects the drugs that are allowed on the market -- even after they're shown to be deadly.